Category: General News

Search News
Categories
Archives
Research highlighted in ASCO annual report on progress against cancer

2nd February 2021

Research led by Professors Peter Schmid and Thomas Powles from Barts Cancer Institute, Queen Mary University of London, has been selected by the American Society of Clinical Oncology (ASCO) for inclusion in the Clinical Cancer Advances 2021, the Society’s annual review of progress against cancer. The notable studies, which investigated the use of immunotherapy in the treatment of triple negative breast cancer and advanced bladder cancer, are featured as two of many remarkable milestones in clinical cancer research and care.

Read more

BCI IT awarded ISO 27001 certification

29th January 2021

Barts Cancer Institute’s IT Department has been awarded with the ISO 27001 certification, which is the international standard that sets out the specification for an information security management system.

Read more

Researchers develop virus-based treatment platform to fight pancreatic cancer

27th January 2021

Researchers from Barts Cancer Institute, Queen Mary University of London, and Zhengzhou University have developed a powerful therapeutic platform that uses a modified virus for the treatment of pancreatic cancer. By using the virus in combination with other drugs, the treatment significantly extended survival in preclinical models of pancreatic cancer.

Read more

CAR T cell therapy for pancreatic cancer

22nd January 2021

Researchers from Barts Cancer Institute, Queen Mary University of London, have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer. Using this protein as a target, the team successfully created a CAR T cell therapy – a type of immunotherapy – that killed pancreatic cancer cells in a pre-clinical model.

Read more

Study receives prize for Research Excellence in Pathology

14th January 2021

Congratulations to Barts Cancer Institute’s Professor Hemant Kocher, who is co-lead author of the paper selected by The Journal of Pathology for the Jeremy Jass Prize for the calendar year 2019.

Read more

PCRF’s national pancreas tissue bank opens to UK-based researchers

11th December 2020

The UK’s national tissue bank for pancreatic diseases at Barts Cancer Institute, Queen Mary University of London, is now open for UK-based researchers needing samples of blood, urine and saliva to aid their research.

Read more

Search News
Categories
Archives